Capricor Therapeutics Inc
NASDAQ:CAPR

Watchlist Manager
Capricor Therapeutics Inc Logo
Capricor Therapeutics Inc
NASDAQ:CAPR
Watchlist
Price: 26.02 USD -4.27% Market Closed
Market Cap: 1.2B USD

Wall Street
Price Targets

CAPR Price Targets Summary
Capricor Therapeutics Inc

Wall Street analysts forecast CAPR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CAPR is 38.96 USD with a low forecast of 20.2 USD and a high forecast of 63 USD.

Lowest
Price Target
20.2 USD
22% Downside
Average
Price Target
38.96 USD
50% Upside
Highest
Price Target
63 USD
142% Upside
Capricor Therapeutics Inc Competitors:
Price Targets
301207
Hualan Biological Bacterin Inc
3% Downside
BIOCON
Biocon Ltd
13% Upside
COV
Covalon Technologies Ltd
109% Upside
XOMA
XOMA Corp
186% Upside
CRNX
Crinetics Pharmaceuticals Inc
62% Upside
RXRX
Recursion Pharmaceuticals Inc
49% Upside
688520
Sinocelltech Group Ltd
21% Upside
ADOC
Adocia SA
121% Upside

Revenue
Forecast

Revenue Estimate
Capricor Therapeutics Inc

For the last 13 years the compound annual growth rate for Capricor Therapeutics Inc's revenue is 24%. The projected CAGR for the next 4 years is 71%.

24%
Past Growth
71%
Estimated Growth
Estimates Accuracy
17%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Capricor Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-13%
Average Miss

Net Income
Forecast

Net Income Estimate
Capricor Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-92%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CAPR's stock price target?
Price Target
38.96 USD

According to Wall Street analysts, the average 1-year price target for CAPR is 38.96 USD with a low forecast of 20.2 USD and a high forecast of 63 USD.

What is Capricor Therapeutics Inc's Revenue forecast?
Projected CAGR
71%

For the last 13 years the compound annual growth rate for Capricor Therapeutics Inc's revenue is 24%. The projected CAGR for the next 4 years is 71%.

Back to Top